Figure 4From: Methotrexate treatment of FraX fibroblasts results in FMR1 transcription but not in detectable FMR1 protein levelsWestern blot analysis after treatment with methotrexate (MTX). Patient fibroblasts were treated with varying concentration of MTX or 5-azadeoxycytidine (5-azadC) 1 μg/ml for 9 days. C = control fibroblasts.Back to article page